Ilan Daskal - Apr 8, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Financial Officer
Signature
/s/ Ilan Daskal
Stock symbol
BIO
Transactions as of
Apr 8, 2022
Transactions value $
-$153,470
Form type
4
Date filed
4/11/2022, 12:16 PM
Previous filing
Sep 8, 2021
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +700 +7777.78% $0.00 709 Apr 8, 2022 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$153K -257 -36.25% $597.16 452 Apr 8, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -700 -33.33% $0.00 1.4K Apr 8, 2022 Bio-Rad A Common Stock 700 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 On April 8, 2019, the reporting person was granted 3,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.